SANTA CLARA, Calif. — Affymetrix, Inc. (Nasdaq:AFFX) has announced three recipients of the 2015 United States Affymetrix Tumor Profiling Grant Program. The grant program, first launched in 2014, is designed to support translational cancer researchers in the discovery and validation of novel diagnostic, prognostic, and therapeutic biomarkers that may address an unmet clinical need. The […]
OMAHA, Neb. — Transgenomic, Inc. (NASDAQ: TBIO) today announced that it has established a Clinical-Commercial Advisory Board (CCAB) for oncology applications of its Multiplexed ICE COLD-PCRTM (MX-ICP) technology. The CCAB is headed by Dr. Scott Patterson, a recognized expert in the application of genetic biomarkers to cancer drug development. Also joining as inaugural CCAB members […]
BILLERICA, Mass.– Bruker Corporation (NASDAQ: BRKR) today announced that it has appointed Dr. Hermann Requardt to its Board of Directors effective immediately. Dr. Requardt will serve for an initial term expiring at the Company’s 2017 Annual Meeting of Stockholders. Dr. Requardt currently serves as an independent strategic advisor to a number of European public and […]
BRISBANE, Calif. and MOUNTAIN VIEW Calif.– CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of actionable diagnostic surveillance solutions for organ transplant recipients, and DNAnexus Inc., the leader in cloud-based genome informatics and data management, today announced that CareDx has selected DNAnexus’ cloud genomics platform to support its ongoing […]
MOUNTAIN VIEW, Calif. — DNAnexus, the leader in cloud-based genome informatics and data management, today announced that the company was awarded a research and development contract by the U.S. Food and Drug Administration’s Office of Health Informatics to build precisionFDA, an open source platform for community sharing of genomic information. precisionFDA is a new approach […]
LEXINGTON, MA – Quanterix Corporation, a leader in high definition diagnostics, today announced that the Journal of Clinical Microbiology has published a new study in which its Simoa (single molecule array) technology was used to develop a rapid, simple tool to allow diagnosis of Clostridium difficile infection (CDI) with both high analytical sensitivity and clinical […]
SAN FRANCISCO — Illumina, Inc. (NASDAQ:ILMN) today announced Illumina Accelerator–the world’s first business accelerator focused solely on creating an innovation ecosystem for the genomics industry–has selected three new startups for its second funding cycle. Selected from a competitive pool of highly qualified applicants, the new startups from across the globe are spurring genomics innovation in […]
BOULDER, CO – InDevR, Inc., an innovative life science company dedicated to improving biopharmaceutical and vaccine manufacturing, announced today the appointment of Elizabeth Malo as Director of Regulatory Affairs. Ms. Malo will be managing and executing InDevR’s regulatory submissions and compliance efforts. Her early focus will be on the FluChip-8G™ in vitrodiagnostic product currently in […]
One company is pioneering advances in drug discovery. Another is transforming the way cancer is identified and tested. A third is improving the health of dairy cattle and reducing the need for small molecule antibiotics in agriculture. The inaugural startups recently graduated from Illumina Accelerator, the world’s first business accelerator charged with helping launch genomic […]
Boulder, Colo. (USA) and Schlieren, Zurich (CH) – Biodesix, Inc., a molecular diagnostics company that discovers and commercializes blood-based diagnostic tests to improve outcomes for patients with cancer, and Biognosys AG, a leader in next-gen proteomics, today announced that Biodesix® will begin offering Biognosys’ HRM technology as part of its companion diagnostic development capabilities to […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
